128 related articles for article (PubMed ID: 27137831)
41. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.
Xu L; Wang Y; Li Y; Wang Y; Cui T; Li J; Jonas JB
Ophthalmology; 2006 Jul; 113(7):1134.e1-11. PubMed ID: 16647133
[TBL] [Abstract][Full Text] [Related]
42. [Side effects of various drugs acting on the eye].
Thurn G
Fortschr Med; 1972 Jun; 90(16):624-8. PubMed ID: 4156346
[TBL] [Abstract][Full Text] [Related]
43. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A
Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115
[No Abstract] [Full Text] [Related]
44. Miotic drugs: a review of ocular, visual, and systemic complications.
Rengstorff R; Royston M
Am J Optom Physiol Opt; 1976 Feb; 53(2):70-80. PubMed ID: 1084694
[TBL] [Abstract][Full Text] [Related]
45. [Antimalarial drugs in contemporary dermatologic therapy].
Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
[TBL] [Abstract][Full Text] [Related]
46. [Therapeutic damage in ophthalmology].
Gernet H
Z Allgemeinmed; 1970 Sep; 46(27):1333-6. PubMed ID: 5472631
[No Abstract] [Full Text] [Related]
47. Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.
Adamcova M; Schaerer MT; Bercaru I; Cockburn I; Rhein HG; Schlagenhauf P
Travel Med Infect Dis; 2015; 13(5):400-8. PubMed ID: 26119539
[TBL] [Abstract][Full Text] [Related]
48. [Synthetic antimalarials and skin].
Ribrioux A
Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
[No Abstract] [Full Text] [Related]
49. Topical retinoids for pigmented skin.
Geria AN; Lawson CN; Halder RM
J Drugs Dermatol; 2011 May; 10(5):483-9. PubMed ID: 21533293
[TBL] [Abstract][Full Text] [Related]
50. Granuloma Annulare.
Keimig EL
Dermatol Clin; 2015 Jul; 33(3):315-29. PubMed ID: 26143416
[TBL] [Abstract][Full Text] [Related]
51. Phototherapy-related ophthalmologic disorders.
DePry J; Brescoll J; Szczotka-Flynn L; Rambhatla P; Lim HW; Cooper K
Clin Dermatol; 2015; 33(2):247-55. PubMed ID: 25704945
[TBL] [Abstract][Full Text] [Related]
52. [Ocular side effects through oral contraceptives (author's transl)].
Rochels R; Nover A
Geburtshilfe Frauenheilkd; 1980 Aug; 40(8):713-5. PubMed ID: 7409430
[TBL] [Abstract][Full Text] [Related]
53. [The eye and drugs].
Payrau P
Eur J Toxicol; 1971; 4(1):60-6. PubMed ID: 4937281
[No Abstract] [Full Text] [Related]
54. [Antimalarial drugs in dermatology. Current situation and prospects].
Gatti S; Zenarola P; Tulli A
G Ital Dermatol Venereol; 1984; 119(2):89-96. PubMed ID: 6735446
[No Abstract] [Full Text] [Related]
55. Skin conditions: new drugs for managing skin disorders.
Nguyen T; Zuniga R
FP Essent; 2013 Apr; 407():11-6. PubMed ID: 23600334
[TBL] [Abstract][Full Text] [Related]
56. Ophthalmologic safety profile of antimalarial drugs.
Rynes RI; Bernstein HN
Lupus; 1993 Feb; 2 Suppl 1():S17-9. PubMed ID: 8485566
[TBL] [Abstract][Full Text] [Related]
57. [Ocular complications of contraception].
Panisset A
Union Med Can; 1975 Oct; 104(10):1549-50. PubMed ID: 1220106
[TBL] [Abstract][Full Text] [Related]
58. Systemic therapy.
van de Kerkhof PC; Braathen LR
Eur J Dermatol; 2009; 19(3):297-301. PubMed ID: 19473957
[No Abstract] [Full Text] [Related]
59. [Harmful effects of common drugs on the visual apparatus. Minor analgesics, antipyretics, nonsteroid anti-inflammatory and antirheumatic drugs].
Watillon M; Robe-Vanwijck A
Bull Soc Belge Ophtalmol; 1972; 160(1):118-69. PubMed ID: 4537985
[No Abstract] [Full Text] [Related]
60. [Oculotoxic and dermatotoxic side effects of phenothiazines].
Garenfeld W; Wilting I
Tijdschr Psychiatr; 2007; 49(4):251-5. PubMed ID: 17436211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
